Literature DB >> 8537317

Purification and characterization of thrombopoietin.

T Kato1, K Ogami, Y Shimada, A Iwamatsu, Y Sohma, H Akahori, K Horie, A Kokubo, Y Kudo, E Maeda.   

Abstract

A thrombopoietic factor, termed thrombopoietin (TPO), was highly purified directly from the plasma of sublethally irradiated 1,100 rats by measuring the production of megakaryocytes from a highly enriched population of rat megakaryocyte progenitor cells (CFU-MK). The rat plasma TPO is a glycoprotein and strongly hydrophobic. The total activity and purification yields obtained were about 29% and 1.49 x 10(8), respectively. The amino acid sequences of the two peptide fragments prepared from the purified 19 kDa TPO were analyzed, and used for the cloning of rat and human TPO cDNAs. It was found that the 19 kDa TPO was truncated but comprised at least 163 amino acids. The sequence of human TPO cDNA revealed that the TPO was identical to the c-Mpl ligand. Both rat and human TPOs expressed in COS-1 cells exhibited significant activity toward the CFU-MK in vitro, and were active in stimulating platelet production in mice. These results indicate that a thrombopoietic factor originally found in the irradiated rat plasma is a ligand for the rat c-Mpl.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537317     DOI: 10.1093/oxfordjournals.jbchem.a124883

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  21 in total

1.  Long-term efficacy of pegylated recombinant human megakaryocyte growth and development factor in therapy of aplastic anemia.

Authors:  Yuji Yonemura; Hirosada Miyake; Norio Asou; Hiroaki Mitsuya
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

Review 2.  Biology and chemistry of thrombopoietic agents.

Authors:  David J Kuter
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

Review 3.  Recent developments in ex vivo platelet production.

Authors:  Retno Wahyu Nurhayati; Yoshihiro Ojima; Masahito Taya
Journal:  Cytotechnology       Date:  2016-03-22       Impact factor: 2.058

4.  Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.

Authors:  A M Farese; P Hunt; L B Grab; T J MacVittie
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

Review 5.  From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.

Authors:  Harinder Gill; Raymond S M Wong; Yok-Lam Kwong
Journal:  Ther Adv Hematol       Date:  2017-02-01

Review 6.  The biology of thrombopoietin and thrombopoietin receptor agonists.

Authors:  David J Kuter
Journal:  Int J Hematol       Date:  2013-07-03       Impact factor: 2.490

7.  Asn-linked sugar chain structures of recombinant human thrombopoietin produced in Chinese hamster ovary cells.

Authors:  N Inoue; T Watanabe; T Kutsukake; H Saitoh; H Tsumura; H Arai; M Takeuchi
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

8.  Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.

Authors:  Keiichi Tozawa; Yukako Ono-Uruga; Masaki Yazawa; Taisuke Mori; Mitsuru Murata; Shinichiro Okamoto; Yasuo Ikeda; Yumiko Matsubara
Journal:  Blood       Date:  2018-11-28       Impact factor: 22.113

Review 9.  New thrombopoietic growth factors.

Authors:  David J Kuter
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

10.  Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Authors:  Michael D Feese; Taro Tamada; Yoichi Kato; Yoshitake Maeda; Masako Hirose; Yasuko Matsukura; Hideki Shigematsu; Takanori Muto; Atsushi Matsumoto; Hiroshi Watarai; Kinya Ogami; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.